Daiichi Sankyo’s Japan Research Foundation for Clinical Pharmacology Awards Its 7th Annual Clinical Pharmacology Research Award

  • Calling pr ads
  • Calling pr ads
Daiichi Sankyo's picture
Printer-friendly versionPrinter-friendly version

For Immediate Release



Representative: Joji Nakayama, Representative Director, President and CEO

(Code no.: 4568, First Section, Tokyo Stock Exchange)

Please address inquiries to Noriaki Ishida, Corporate Officer,

Vice President, Corporate Communications Department

Telephone: +81-3-6225-1126


Daiichi Sankyo’s Japan Research Foundation for Clinical Pharmacology Awards Its 7th Annual Clinical Pharmacology Research Award

Tokyo, Japan (June 20, 2014) – Daiichi Sankyo Company, Limited today announced that its affiliate, the Japan Research Foundation for Clinical Pharmacology* (headquarters, Tokyo; Director General, Kiyoshi Morita), has awarded its 7th “Japan Research Foundation for Clinical Pharmacology Research Award” to five young researchers.


Award recipients are selected from research papers submitted from projects funded with subsidies from the foundation. Innovative research projects with expectations for future development are eligible for the award.


The Foundation hopes that this award will motivate young clinical pharmacology researchers who are involved in the establishment of appropriate drug treatments and encourage future research results. The awards ceremony and presentation of research themes will be held on November 11, 2014.


*The mission of the Foundation is to promote clinical pharmacology and foster the development of clinical pharmacologists. The Foundation was established in 1975 and has worked on a variety of projects relating to clinical pharmacology, including promotion of research, overseas studies for Japanese researchers, and international collaborations in Asia.

Recipients of the 7th Japan Research Foundation for Clinical Pharmacology Research Award




Research theme



Department of Periodontology

School of Dental Medicine

Tsurumi University

The establishment and safety verification of controlled release of platelet-rich plasma impregnated in biodegradable gelatin hydrogel with new periodontal regeneration


Department of Surgery

Graduate School of Medicine

Kyoto University

Evaluation of chemokine receptors inhibition for the prevention of colon cancer metastasis



Department of Organ Network and Metabolism
Graduate School of Medical and Dental Sciences

Tokyo Medical and Dental University

Development of novel therapeutic strategies for non-alcoholic steatohepatitis using an unique mouse model



Laboratory of Pharmacotherapy of Life-style Related Diseases

Graduate School of Pharmaceutical Sciences

Tohoku University

Prediction of inter-individual difference in drug metabolism :

Functional characterization of 32 CYP2C9 allelic variants using warfarin


Department of Hospital Pharmacy Hamamatsu University School of Medicine

Inosine 5’-monophosphate dehydrogenase activity in

systemic lupus erythematosus

Copy this html code to your website/blog to embed this press release.


Post new comment

4 + 3 =

To prevent automated spam submissions leave this field empty.